PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Posted on by sciencefather

Dr. PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Dr. PANAGIOTA TSIATSIOU, AHEPA UNIVERSITY HOSPITAL, Greece

Dr. Panagiota Tsiatsiou is a dedicated medical biopathologist with over two decades of service in the Greek National Health System. Born on March 17, 1969, in Thessaloniki, Greece, she earned her M.D. from the Aristotle University of Thessaloniki and has specialized in hematology diagnostics, molecular biology, and public health. Since 2011, she has served in the Hematology Section at AHEPA University Hospital and was appointed Director in 2018. Her role extends beyond diagnostics to include leadership, training of residents, and managing lab operations, especially during the COVID-19 pandemic. With three Master’s degrees and active participation in scientific publications and conferences, Dr. Tsiatsiou continues to bridge clinical practice and research. Her work on angiopoietins and biomarkers in COVID-19 patients demonstrates her commitment to innovative healthcare solutions and translational medicine.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Extensive Clinical and Laboratory Expertise
    Over 20 years of experience in microbiology and hematology laboratories, with advanced specialization in Medical Biopathology, PCR techniques, and molecular hematology.

  2. Research Impact in COVID-19
    Lead author in two recent international peer-reviewed publications (2024, 2025) on angiopoietins and endothelial damage in COVID-19—topics of significant relevance in post-pandemic biomedical research.

  3. Academic Qualifications
    Holder of three Master’s degrees in Health Services Management, Public Health, and Biomedical Sciences—demonstrating a strong interdisciplinary foundation and commitment to academic excellence.

  4. Mentorship and Leadership
    Director of the Hematology Section at AHEPA University Hospital since 2018; deeply involved in resident training and lab coordination, especially during the pandemic, proving strong leadership under crisis.

  5. Scientific Contribution

    • 6 publications (4 international, 2 Greek)

    • 99 scientific papers

    • Participation in 158 scientific conferences, workshops, and seminars—highlighting strong engagement with the research community.

⚠️ Areas for Improvement:

  1. Global Visibility
    While research quality is high, international recognition could be improved by targeting higher-impact journals and expanding collaborations outside Greece.

  2. Grants and Funding Leadership
    CV does not specify involvement in research grant acquisition or project funding management—which are often critical metrics in high-level research awards.

  3. Innovation and Patents
    There is no mention of patents, technological innovation, or industry partnerships, which could further enhance her scientific portfolio.

  4. Broader Publication Scope
    Expanding beyond COVID-19-related studies to publish more widely in hematologic and molecular diagnostics would strengthen her long-term research narrative.

🎓 Education:

Dr. Tsiatsiou holds a solid educational background in medicine and public health. She completed her M.D. at the Aristotle University of Thessaloniki (1988–1995), followed by rural service and specialization in Medical Biopathology at Theageneio Anticancer Hospital, obtaining her board certification in 2002. She pursued a Master’s in Health Services Management (2005–2008) at the Hellenic Open University, focusing on blood donor psychology. She furthered her expertise with a Master’s in Public Health at the National School of Public Health, where she studied foodborne infections. Additionally, she obtained a Master’s in Biomedical Sciences with a concentration in Diagnosis and Therapy, focusing on genetic mutations like FV Leiden. Her academic trajectory reflects a deep interdisciplinary approach—combining clinical knowledge, health systems, and research.

🏥 Experience:

Dr. Tsiatsiou’s clinical career spans more than 20 years, primarily within Greece’s National Health System. From 2003 to 2020, she served in various microbiology labs, refining her diagnostic skills. Since July 2011, she has worked in the Hematology Section at AHEPA University Hospital, leading the unit since 2018. Her expertise includes hemostasis, hemoglobinopathies, and molecular testing, and she has been instrumental in staff training and lab management. She led the hemostasis lab during the COVID-19 pandemic, ensuring continuity and quality of diagnostics under pressure. Her dedication to resident education in both Medical Biopathology and General Medicine has made her a respected mentor. Dr. Tsiatsiou’s leadership has elevated the lab’s scientific output, and her involvement in over 150 conferences showcases her engagement with ongoing medical developments.

🔬 Research Focus:

Dr. Tsiatsiou’s research is centered on hematology diagnostics, hemostasis disorders, and molecular markers in infectious diseases. Her most recent work investigates endothelial damage and angiopoietin levels as predictors in COVID-19 patients during the Delta and Omicron waves. This research bridges laboratory medicine with clinical outcomes, offering vital insights into disease severity and prognostics. She also explores genetic predispositions, such as FV Leiden mutations, in thrombotic risk profiling. Her postgraduate theses and training in PCR and molecular hematology underscore her commitment to translational science. With 6 peer-reviewed publications and 99 scientific papers, her academic output is diverse and impactful. Dr. Tsiatsiou’s multidimensional research contributes not only to hematology but also to public health and epidemiology, making her work highly relevant in modern medicine and worthy of recognition.

📚 Publications Top Notes:

  1. 📄 Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients, Current Issues in Molecular Biology, 2025

  2. 📄 Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology, 2024

  3. 📄 Thesis: Trends, Attitudes, and Motivations of Blood Donors and Non-Donors – Hellenic Open University

  4. 📄 Thesis: Foodborne Infections in Urban and Rural Populations of Central Macedonia – National School of Public Health

  5. 📄 Thesis: Prevalence of FV Leiden Mutation in a Tertiary Hospital – Democritus University of Thrace & IHU

  6. 📄 Additional 99 scientific papers and 158 participations in academic events

🧾 Conclusion:

Dr. Panagiota Tsiatsiou is a highly qualified and impactful researcher with significant contributions in hematology, molecular diagnostics, and public health. Her recent publications in Current Issues in Molecular Biology show scientific depth and relevance, especially regarding the clinical progression of COVID-19. She is an excellent candidate for a national or institutional Best Researcher Award, particularly in medical diagnostics and laboratory medicine.

An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Posted on by sciencefather

Mr. An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Mr. An Dai Tran, Walailak University, Vietnam

Dr. An Dai Tran is a dedicated medical doctor and emerging public health researcher from Vietnam, currently pursuing a Master’s degree at Walailak University, Thailand. He works at the CDC Dong Thap, focusing on vaccination programs and infectious disease control, including dengue fever, COVID-19, and measles. With several years of hands-on experience in clinical trials and epidemiological research, Dr. Tran has made significant contributions to community health. His published work on vaccination adherence among minority groups in Vietnam has had real-world impact on public health campaigns. Additionally, he has co-developed innovative tools for behavioral science and contributed to machine learning applications in mental health. Collaborating with global institutions such as the University of Queensland and the Pasteur Institute, Dr. Tran’s work reflects a commitment to translational research, public health equity, and data-driven health interventions. His profile is marked by scientific rigor, international collaboration, and service to underserved populations.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Interdisciplinary Research Excellence
    Dr. Tran’s research spans infectious diseases, vaccination behavior, and digital mental health—demonstrating versatility and innovation in addressing modern public health challenges.

  2. Practical and Policy-Relevant Impact
    His work on vaccination adherence in minority communities has real-world implications for national health policy and outreach programs, especially in underserved populations.

  3. Strong Clinical Trial Experience
    He has held critical roles in major vaccine trials (COVID-19 and hand-foot-mouth disease), showing competence in trial design, blinding, and coordination—essential for translational health research.

  4. Collaborative Global Network
    Dr. Tran has established collaborations with renowned institutions such as the University of Queensland and the Pasteur Institute, boosting the credibility and scalability of his research.

  5. Innovation in Mental Health Analytics
    His application of AI and machine learning to post-COVID mental health challenges shows forward-thinking research methodology with future potential.

  6. Published and Cited
    With publications in peer-reviewed journals like Jornal de Pediatria and Journal of Human, Earth, and Future, and a growing citation index, he is building a solid academic foundation.

🛠️ Areas for Improvement:

  1. Broader Indexing and Citations
    While promising, most of his current publications are in emerging or interdisciplinary journals. Publishing in higher-impact, SCI-indexed journals could enhance academic visibility.

  2. Editorial and Peer Review Roles
    Taking on editorial appointments or peer-review duties would strengthen his professional profile and leadership in research.

  3. Mentorship and Teaching Contribution
    Engaging in formal mentorship or academic teaching roles would reflect his potential as a knowledge disseminator and academic influencer.

  4. Expanded Public Health Policy Impact
    Future work that integrates direct contributions to policy development or national programs would further validate his applied research strengths.

🎓 Education:

Dr. An Dai Tran holds a medical degree and is currently completing a Master’s in Public Health at the School of Public Health, Walailak University, Thailand. He was awarded a full scholarship for his postgraduate studies in recognition of his academic excellence and commitment to public health. His education bridges clinical medicine with population-level health sciences, equipping him with multidisciplinary expertise to tackle emerging global health challenges. At Walailak University, Dr. Tran has deepened his knowledge in epidemiology, biostatistics, global health policy, and digital health technologies. His academic training is complemented by a strong foundation in research methodology and ethics, allowing him to conduct high-impact studies and clinical trials. His exposure to both theoretical and practical facets of public health, along with mentorship from international experts, positions him as a future leader in healthcare innovation, with special focus on vaccine-preventable diseases and mental health research in Southeast Asia.

💼 Professional Experience:

Dr. Tran brings valuable on-ground experience through his work at the CDC Dong Thap in Vietnam, where he has led and supported various national vaccination campaigns and infectious disease monitoring systems. He has been actively involved in both the operational and research aspects of public health interventions. His clinical trial roles include coordinating blinded and double-blinded studies on COVID-19 and hand-foot-mouth vaccines. Notably, he served as a research coordinator in large-scale, placebo-controlled trials with rigorous ethical and methodological frameworks. His consultancy record includes four projects in collaboration with governmental and academic institutions, such as the University of Queensland (E-Dengue Project) and the Pasteur Institute (Vietnam-based vaccine research). Dr. Tran’s experience spans public health research, disease surveillance, behavioral analysis, and machine learning for mental health prediction. His combined roles as physician, coordinator, and academic researcher highlight his versatility, responsibility, and drive for impactful health innovations that reach marginalized communities.

🧠 Research Focus:

Dr. Tran’s research lies at the intersection of infectious diseases, vaccination behavior, and digital mental health. His primary interest is understanding the behavioral and sociocultural factors affecting vaccine uptake, particularly among ethnic minority populations. His first-author publication on this topic has already contributed to improved regional strategies for vaccine delivery. Expanding into digital health, Dr. Tran has co-developed psychological assessment tools and applied machine learning to detect mental health issues in post-COVID patients. His work in computational psychiatry includes Reddit-based community sentiment analysis and comparative modeling for long COVID mental health prediction. By merging AI with public health, he aims to enhance early detection and intervention systems. His approach reflects a holistic vision—bridging clinical practice, community outreach, and technology—with a commitment to healthcare equity. Dr. Tran’s research is not only academically sound but also practically applicable, aligning with Sustainable Development Goals (SDGs) for health and well-being.

📚 Publications Top Notes:

  1. 🧬 Parental predictors of childhood vaccination adherence in border areas of Southern Vietnam – Jornal de Pediatria.

  2. 🏃‍♂️ Initial Construction of the Exercise Maintenance Motivation Scale: A Mixed Method Study – Journal of Human, Earth, and Future.

  3. 🤖 An Analysis of Machine Learning for Detecting Depression, Anxiety, and Stress of Recovered COVID-19 Patients – Journal of Human, Earth, and Future.

  4. 🧠 Exploring Mental Stress Expressions in Online Communities: A Subreddit Analysis – Journal of Human, Earth, and Future.

  5. 🧪 Mental health and long COVID status prediction among recovered COVID-19 patients: A comparison of machine learning methods – Journal of Human, Earth, and Future.

🧾 Conclusion:

Dr. An Dai Tran is a highly promising early-career researcher whose interdisciplinary work in public health is both scientifically rigorous and socially impactful. His blend of clinical trial expertise, digital health innovation, and public health behavior research makes him an ideal candidate for the Best Researcher Award. While there is room to grow in areas like journal prestige and academic leadership, his current trajectory, achievements, and commitment to health equity clearly demonstrate award-worthy excellence.

Bárbara Verçosa | Host-Pathogen Interactions | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Bárbara Verçosa | Host-Pathogen Interactions | Best Researcher Award

Prof. Dr. Bárbara Verçosa , Faculdade de Saude Pitágoras Codó , Brazil

Bárbara Laurice Araújo Verçosa, a Brazilian researcher and veterinarian, specializes in veterinary pathology and the study of leishmaniasis. She holds a Doctorate in Biology (2015) from Universidade Federal de Minas Gerais, with a focus on renal response in canine visceral leishmaniasis. She is a committed educator and scientific researcher, contributing extensively to the fields of veterinary medicine and animal pathology. She has published numerous papers in international journals, participated in various academic and professional events, and is an active member of editorial boards. Her contributions to veterinary science, especially in the study of inflammatory responses and apoptosis in leishmaniasis, have earned her recognition both nationally and internationally.

Publication Profile:

Scopus

Strengths for the Award:

  1. Academic Qualifications and Research Focus:
    Dr. Verçosa has a strong academic background, with a Doctorate in Biology from the Universidade Federal de Minas Gerais (UFMG) and a Master’s degree in Pathological Anatomy and Clinical Pathology from the same institution. Her research focuses on canine visceral leishmaniasis, which is highly relevant and impactful in veterinary medicine. Her expertise in apoptosis, inflammation, fibrosis, and renal pathology related to infectious diseases shows a high level of specialization and contribution to the field.
  2. Research Publications:
    Dr. Verçosa has an impressive publication record with 23 articles in reputable scientific journals, including high-impact journals such as Microbial Pathogenesis, Molecular Immunology, and Veterinary Parasitology. Additionally, she has authored books and chapters and has presented her research at numerous conferences. The breadth and depth of her publications demonstrate her active contribution to advancing knowledge in veterinary medicine, particularly in parasitic diseases.
  3. Experience and Knowledge:
    With significant experience in pathology, veterinary medicine, and molecular diagnostics, she brings a holistic understanding of both the basic and applied aspects of her field. Her experience in teaching, mentoring graduate students, and serving as a scientific journal referee further exemplifies her leadership in the academic and research community.
  4. Awards and Recognition:
    Dr. Verçosa’s work has been recognized with multiple awards such as the Menção Honrosa at the Seminário de Iniciação Científica and the 1st Prize in Scientific Initiation from Fapepi. These awards highlight her early career achievements and ongoing recognition in her research contributions.
  5. International Recognition and Collaborations:
    Dr. Verçosa is an active contributor to international research, with collaborations and refereeing roles in journals such as the Journal of Pharmaceutical Research International and the Asian Journal of Advances in Research, which reflects her international recognition and commitment to global scientific dialogue.

Areas for Improvement:

  1. Increase Interdisciplinary Collaborations:
    While Dr. Verçosa’s expertise is mainly within the veterinary and biological sciences domain, exploring interdisciplinary research with fields like public health, epidemiology, and clinical veterinary practices could further broaden the impact of her work, especially considering the public health implications of diseases like Leishmaniasis.
  2. Expanding Research into Novel Treatment Approaches:
    Given the ongoing challenges in treating Leishmaniasis in animals, expanding her research to explore new treatment protocols or innovative therapies in collaboration with clinicians could be a valuable area of growth. Exploring how her findings in inflammatory response and fibrosis can lead to better therapeutic options could strengthen the clinical relevance of her work.
  3. Increased Public Engagement:
    While her publications are substantial in academic circles, increasing public engagement through outreach programs or community awareness initiatives about canine Leishmaniasis and other diseases she studies could enhance her contribution to society. This could help bridge the gap between research and practical applications for the broader population.

Education:

Bárbara Verçosa holds a Doctorate (2015) in Biology from Universidade Federal de Minas Gerais (UFMG), Brazil, where she focused on inflammatory responses and apoptosis in dogs infected with Leishmania. She completed her Master’s in Pathological Anatomy and Clinical Pathology at UFMG in 2010, investigating apoptosis in naturally infected dogs. She earned her Veterinary Medicine degree from Universidade Federal do Piauí (UFPI) in 2007, specializing in the inflammatory responses in canine leishmaniasis. Additionally, Verçosa has participated in postdoctoral research at Universidade de Brasília (UnB), focusing on health sciences, and has completed several continuing education courses in diagnostic imaging, molecular diagnostics, and animal pathology.

Experience:

Verçosa has extensive academic and professional experience in veterinary medicine and pathology. She served as a faculty member at Universidade Regional do Cariri (URCA) and currently teaches at Faculdade de Ciências da Saúde Pitágoras Codó. She has been involved in research, graduate supervision, and clinical training in veterinary anatomy and pathology. Her research focus includes canine leishmaniasis, inflammatory responses, and apoptotic processes in infected tissues. Her career also includes several trainee and research positions, particularly in animal pathology at UFPI, and clinical practice in large animal surgery. Verçosa’s international exposure includes teaching and research roles at UFMG, where she taught pathology to veterinary students. Her involvement in research and scientific publication spans many years, with a focus on advancing the understanding of animal diseases through detailed anatomical and molecular studies.

Awards and Honors:

Bárbara Verçosa has received multiple awards for her research and academic contributions. Notably, she received two Honorable Mentions in 2006 for her presentations at the XIV Seminário de Iniciação Científica at UFPI. She was also awarded the 1st Prize for Scientific Initiation by Fapepi, the Foundation for Research Support of the State of Piauí, in 2005. These recognitions highlight her early dedication to scientific research. Verçosa’s career has also been distinguished by her scholarships from CAPES and CNPq, which supported her doctoral and master’s research. Her research excellence has been further validated by her ongoing involvement in prestigious journals as a reviewer, alongside her role in various editorial boards. Her academic achievements reflect her significant contributions to the fields of veterinary science and animal pathology.

Research Focus:

Bárbara Verçosa’s research primarily focuses on veterinary pathology, particularly in the context of visceral leishmaniasis in dogs. Her studies explore the inflammatory response, apoptosis, and fibrosis in organs affected by this parasitic disease. She investigates the molecular and histomorphometric changes in canine renal tissues, with an emphasis on the interactions between immune responses and tissue damage. Verçosa’s work also covers the role of chemokines, cytokines, and apoptosis markers in understanding the disease’s pathogenesis. Her research extends into other areas of veterinary pathology, including the study of animal inflammatory diseases and zoonotic diseases. Through her studies, she aims to contribute to improving diagnostic, therapeutic, and preventive measures for animal health. Verçosa’s interdisciplinary approach combines molecular biology, histopathology, and clinical studies, positioning her as a leading expert in veterinary parasitology.

Publications Top Notes:

  1. Enhanced apoptotic index in hepatocytes, Kupffer cells, and inflammatory infiltrate showed positive correlation with hepatic lesion intensity, parasite load, and clinical status in naturally Leishmania-infected dogs. (MICROBIAL PATHOGENESIS) 📚🦠
  2. MCP-1/IL-12 ratio expressions correlated with adventitial collagen depositions in renal vessels and IL4/IFN-γ expression correlated with interstitial collagen depositions in the kidneys of dogs with canine leishmaniasis. (MOLECULAR IMMUNOLOGY) 🧬🦠
  3. Nucleolar organizer region proteins enhancement in nucleoplasm’s of renal tubular cells is an indication of kidney impairment in Leishmania-infected dogs. (VETERINARY PARASITOLOGY) 🦠🧪
  4. Enhanced apoptotic index, chemokines and inflammatory recruitment in renal tissues shows relationship with the clinical signs in Leishmania-infected dogs. (VETERINARY PARASITOLOGY) 🔬🐶
  5. The balance between IL-12/IL4 in renal tissue switches the inflammatory response arm and shows relationship with the clinical signs in Leishmania-infected dogs (Veterinary Immunology and Immunopathology, 2021).

Conclusion:

Dr. Bárbara Laurice Araújo Verçosa is a highly accomplished and well-regarded researcher in the field of veterinary medicine, particularly in pathology and infectious diseases. Her extensive research publications, awards, and international collaborations are a testament to her expertise and impact in the field. The areas identified for improvement are relatively minor and pertain to enhancing the breadth and public visibility of her work. Overall, her scientific contributions make her an excellent candidate for the Best Researcher Award.

 

 

 

 

Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Posted on by sciencefather

Dr. Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Dr. Huiying Fan , College of Veterinary Medicine, South China Agricultural University , China

Dr. Huiying Fan is a distinguished professor and doctoral supervisor at the College of Veterinary Medicine, South China Agricultural University, specializing in veterinary virology and immunology. As a core member of the Key Laboratory for Veterinary Vaccine Development, his expertise includes creating genetically engineered vaccines for animal viruses. Dr. Fan has published over 40 research papers in leading journals, including Journal of Virology and Emerging Microbes & Infections, and holds 11 invention patents. His career has been marked by significant contributions to animal virus research and vaccine development, with extensive involvement in national research programs. He has been recognized with several provincial and ministerial-level awards and is actively involved in scientific development and industry collaboration in China.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Huiying Fan has demonstrated exceptional contributions to the field of veterinary virology and immunology, particularly in the development of vaccines for animal viruses. He is a recognized leader in the creation of genetically engineered vaccines, with over 40 SCI papers published in high-impact journals such as Journal of Virology, Emerging Microbes & Infection, and Vaccines. His involvement in groundbreaking research on the pathogenic mechanisms of viruses like avian influenza, porcine epidemic diarrhea, and African swine fever underscores his expertise. Furthermore, Dr. Fan has been granted 11 invention patents and is an influential figure in national research programs, such as the National Key Research and Development Program. His leadership as a professor and mentor, coupled with his ongoing innovations in virus detection and vaccine development, showcases his remarkable impact in the field.

Areas for Improvement:

While Dr. Fan’s scientific research has been groundbreaking, expanding his focus on broader global collaborations could enhance the scope of his work. In particular, his work could benefit from incorporating more interdisciplinary approaches, combining cutting-edge technologies such as artificial intelligence or big data analytics, which are becoming increasingly crucial in disease surveillance and vaccine development. Moreover, his research could further address the application of his vaccine technologies in low-resource settings, to maximize global health impact. Engaging more actively in science communication could also help translate his findings into policies or programs that benefit larger populations, both within China and internationally.

Education:

Dr. Fan completed his Ph.D. in Preventive Veterinary Medicine at the College of Veterinary Medicine, Huazhong Agricultural University, in June 2007. During his doctoral research, he focused on the study of veterinary diseases and virus-host interactions, laying a strong foundation for his future work in vaccine development. His commitment to advancing veterinary science continued through postdoctoral training, followed by his establishment as a professor at South China Agricultural University. His education reflects his dedication to merging academic research with practical applications for the improvement of animal health and disease prevention.

Experience:

Dr. Fan’s career began in 2007 as a professor at South China Agricultural University, where he became a leading figure in veterinary medicine. He has also contributed significantly to international research, evidenced by his six-month research visit to City University of Hong Kong in 2016. As a core member of several high-impact research initiatives, including the National Key Research and Development Program, he has played a vital role in advancing veterinary virology and vaccine development. Dr. Fan’s extensive expertise has led to collaborations across national projects and scientific endeavors, particularly in the realm of infectious diseases and immune responses in animals.

Awards and Honors:

Dr. Fan has received multiple prestigious awards throughout his career, including 8 provincial and ministerial-level honors. Notably, he was named a “Pearl River Science and Technology Star” in Guangzhou and recognized as a “Science and Technology Commissioner” by the People’s Government of Guangdong Province. His contributions to veterinary science have garnered recognition both within China and internationally, highlighting his commitment to scientific excellence and industry collaboration. These accolades underscore his leadership in veterinary vaccine research and his influence on public health initiatives concerning animal diseases.

Research Focus:

Dr. Fan’s primary research interests lie in the molecular design of genetically engineered vaccines for animal viruses, including those affecting poultry and swine. His studies explore the immune mechanisms and pathogenesis of viruses such as avian influenza and porcine viral diarrhea. In addition to his work on vaccine development, he investigates the use of innovative techniques, including CRISPR/Cas12a and proteomics, to better understand virus-host interactions and to improve diagnostic and therapeutic strategies for animal diseases. His focus on veterinary virology aims to enhance both animal and public health outcomes.

Publication Top Notes:

  1. “A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses” 🐔🦠
  2. “Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability” 🦠❄️
  3. “Immune Escape Mechanism and Vaccine Research Progress of African Swine Fever Virus” 🐖🦠
  4. “Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection” 🦠💉
  5. “PEDV infection affects the expression of polyamine-related genes inhibiting viral proliferation” 🐖🧬
  6. “Proteome Analysis in PAM Cells Reveals That African Swine Fever Virus Can Regulate Intracellular Polyamines” 🧬🔬
  7. “CRISPR/Cas12a Technology Combined with Immunochromatographic Strips for Portable Detection of ASF Virus” 🧬🦠
  8. “Quantitative Proteomics Reveals Changes in Vero Cells in Response to Porcine Epidemic Diarrhea Virus” 🐖🔬
  9. “Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of H5N1 vaccine” 💉🦠
  10. “Either fadD1 or fadD2, Which Encode acyl-CoA Synthetase, Is Essential for the Survival of Haemophilus parasuis SC096” 🦠🔬
  11. “Two Glycosyltransferase Genes of Haemophilus parasuis SC096 Implicated in Lipooligosaccharide Biosynthesis” 🧬🦠
  12. “Recombinant baculovirus vaccine containing multiple M2e and adjuvant LT induces T cell-dependent protection against H5N1” 💉🦠
  13. “BacMam virus-based surface display of IBV S1 glycoprotein confers strong protection against virulent IBV challenge” 🐔🦠
  14. “Quantitative Proteomics by Amino Acid Labeling in Foot-and-Mouth Disease Virus-Infected Cells” 🐄🧬
  15. “Quantitative proteomics using SILAC reveals protein and pathway regulation in porcine circovirus type 2 infected PK-15 cells” 🐖🧬

Conclusion:

Dr. Huiying Fan is undoubtedly a strong contender for the Research for Best Researcher Award, given his outstanding contributions to animal virus research, innovative vaccine design, and leadership in national research initiatives. His extensive publication record, patent portfolio, and recognition through prestigious awards highlight his scientific excellence. Although expanding his collaborative network and exploring interdisciplinary methodologies could elevate his impact further, Dr. Fan’s work has already had a profound effect on veterinary medicine and public health, making him a well-deserved nominee for this award.